The Diabetic Foot

Clinical Diabetes

Volumn , Issue , 2006, Pages 179-195

  Boulton, Andrew J M ^a,b,c   Armstrong, David G ^d,e  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^e ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882538748     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0273-4.50019-9     Document Type: Chapter

References (128)

1. International Working Group on the Diabetic Foot. International Consensus on the Diabetic Foot. Amsterdam, International Diabetes Federation, 1999.
2. Mayfield JA, Reiber GE, Sanders LJ, et al. Preventive footcare in people with diabetes. Diabetes Care 1998, 21:2161-2177.
3. Consensus development conference on diabetic wound care. Diabetes Care 1999, 22:1354-1360. American Diabetes Association.
4. Boulton AJM, Kirsner RS, Vileikyte L Neuropathic diabetic foot ulcers. N Engl J Med 2004, 351:48-55.
5. Morrison EY Diabetes foot amputations as the most frequent diabetes complication in developing countries. IDF Bull 1997, 42:14-17.
6. Mbanya JC, Sobngwi E Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa. J Cardiovasc Risk 2003, 10:97-102.
7. Shaw JE, Zimmett PZ The epidemiology of diabetic neuropathy. Diabetes Rev 1999, 6:245-252.
8. Williams DRR, Airey M The size of the problem: Epidemi-ological and economic aspects of the diabetic foot. The Foot in Diabetes 2000, 3-17. Wiley, Chichester. 3rd ed. A.J.M. Boulton, H. Connor, P.R. Cavanagh (Eds.).
9. Reiber GE, Ledoux WR Epidemiology of diabetic foot ulcers and amputations: Evidence for prevention. The Evidence Base for Diabetes Care 2002, 641-665. Wiley, Chichester. R. Williams, W. Herman, A.L. Kinmonth, N.J. Wareham (Eds.).
10. Carrington AL, Abbott CA, Griffiths J, et al. A foot care program for diabetic unilateral amputees. Diabetes Care 2001, 24:216-221.
11. Faglia E, Favales F, Moratibo A New ulceration, new major amputation and survival rates in diabetic subjects hospitalised for foot ulceration from 1990-1993: A 6.5 year follow-up. Diabetes Care 2001, 24:78-83.
12. Kumar S, Ashe H, Fernando DJS, et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: A population-based study. Diabet Med 1994, 11:480-484.
13. Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002, 20:377-384.
14. Muller IS, de Grauw WJ, van Gerwen WH, et al. Foot ulceration and lower limb amputation in type 2 diabetic patients in Dutch primary health care. Diabetes Care 2002, 25:570-574.
15. Lavery LA, Armstrong DG, Wunderlich RP, et al. Diabetic foot syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes management cohort. Diabetes Care 2003, 26:1435-1438.
16. Humphrey ARG, Thomas K, Dowse GK, Zimmet PZ Diabetes and non-traumatic lower extremity amputations. Incidence, risk factors and prevention: A 12 year follow-up study in Nauru. Diabetes Care 1996, 19:710-716.
17. Belhadj M La place du pied diabetique. Diabete Metab 1998, 24(suppl 1). LXVII.
18. Pendsey S Epidemiological aspects of the diabetic foot. J Diabetes Develop Countries 1994, 2:37-38.
19. Gulliford MC, Mahabir D Diabetic foot disease in a Caribbean community. Diabet Res Clin Pract 2003, 56:35-40.
20. Young MJ, Veves A, Breddy JL, Boulton AJM The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: A prospective study. Diabetes Care 1994, 17:557-560.
21. Abbott CA, Vileikyte L, Williamson S, et al. Multicentre study of the incidence of and predictive factors for diabetic neuropathic foot ulcers. Diabetes Care 1998, 21:1071-1075.
22. Larsson J, Apelqvist J, Agardh GD, Stenstrom A Decreasing incidence of major amputation in diabetic patients: A consequence of a multidisciplinary foot care team approach?. Diabet Med 1995, 12:770-776.
23. Trautner C, Haastert B, Spraul M, et al. Unchanged incidence of lower limb amputations in a German city 1990-1998. Diabetes Care 2001, 24:855-859.
24. Trautner C, Haastert B, Giani C, Berger M Amputations and diabetes: A case-control study. Diabet Med 2002, 19:35-40.
25. Anonymous An audit of amputations in a rural health district. Pract Diabet Int 1997, 14:175-178.
26. Toledano H, Young MJ, Veves A, Boulton AJM Why do Asian diabetic patients have fewer foot ulcers than Caucasians?. Diabet Med 1993, 10(suppl 1):539.
27. Chaturvedi N, Abbott CA, Whalley A, et al. Risk of diabetes-related amputation in south Asians vs Europeans in the UK. Diabet Med 2002, 19:99-106.
28. Leggetter SY, Chaturvedi N, Fuller JH, Edmonds ME Ethnicity and risk of diabetes-related lower extremity amputation: A population-based, case-control study of Afro-Caribbeans and Europeans in the United Kingdom. Arch Int Med 2001, 162:73-78.
29. Resnick HE, Valsania P, Phillips CL Diabetes mellitus and non-traumatic lower extremity amputation in black and white Americans: The National Health and Nutrition Examination Survey epidemiology follow-up study 1971-1992. Arch Int Med 1999, 159:2470-2475.
30. Shearer A, Scuffham P, Gordois A, Ogleshy A Predicted costs and outcomes from reduced vibration detection in people with diabetes in the US. Diabetes Care 2003, 26:2305-2310.
31. Ragnarson-Tennvall G, Apelqvist J Prevention of diabetes-related foot ulcers and amputations: A cost-utility analysis based on Markov model simulation. Diabetologia 2001, 44:2077-2087.
32. Assal JP, Mehnert H, Tritschler HS, et al. "On your feet" workshop on the diabetic foot. J Diabet Comp 2002, 16:183-194.
33. Ramsey SD, Newton K, Blough D, et al. Incidence outcomes and costs of foot ulcers in patients with diabetes. Diabetes Care 1999, 22:382-387.
34. Comparing the incidence of lower extremity amputation across the world: The global lower extremity amputation study. Diabet Med 1995, 12:14-18. LEA Study Group.
35. Joslin EP The menace of diabetic gangrene. N Engl J Med 1934, 211:16-20.
36. Vileikyte L, Rubin RR, Leventhal H Psychological aspects of diabetic neuropathic foot complications: An overview. Diabetes Metab Res Rev 2004, 20(suppl 1):S13-S18.
37. Boulton AJM Pressure and the diabetic foot: Clinical science and offloading techniques. Am J Surg 2004, 187(5A):175-245.
38. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathway for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999, 22:157-162.
39. Morbach S, Lutale JK, Viswanathan V, et al. Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabet Med 2004, 21:91-95.
40. Boulton AJM, Hardisty CA, Betts RP, et al. Dynamic foot pressure and other studies as diagnostic and management aids for diabetic neuropathy. Diabetes Care 1983, 6:26-33.
41. Katoulis EC, Ebdon-Parry M, Hollis S, et al. Postural instability in diabetic patients at risk of foot ulceration. Diabet Med 1997, 14:296-300.
42. Katoulis EC, Ebdon-Parry M, Lanshammar H, et al. Gait abnormalities in diabetic neuropathy. Diabetes Care 1997, 20:1904-1907.
43. Young MJ, Boulton AJM, MaCleod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the UK hospital clinic population. Diabetologia 1993, 36:150-154.
44. Mayfield JA, Sugarman JR The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract 2000, 49(11 suppl):S17-S29.
45. Booth J, Young MJ Differences in the performance of commercially available monofilaments. Diabetes Care 2000, 23:984-988.
46. Jude EB, Oyibo SO, Chalmers N, Boulton AJM Peripheral arterial disease in diabetic and non-diabetic patients: A comparison of severity and outcome. Diabetes Care 2001, 24:1433-1437.
47. Abbott RD, Brand FN, Kannel WB Epidemiology of some peripheral arterial findings in diabetic men and women: Experiences from the Framingham study. Am J Med 1990, 88:376-381.
48. Siitonen OI, Niskanen LK, Laasko M, et al. Lower extremity amputation in diabetic and non-diabetic patients: A population based study in Eastern Finland. Diabetes Care 1993, 16:16-20.
49. Pecoraro RE, Reiber GE, Burgess EM Pathways to diabetic limb amputations: Basis for prevention. Diabetes Care 1990, 13:513-521.
50. Flynn MD, Tooke JE Aetiology of diabetic foot ulceration: A role for the microcirculation?. Diabet Med 1992, 9:320-329.
51. Veves A, Young MJ, Murray HJ, Boulton AJM The risk of foot ulceration in diabetic patients with high foot pressures: A prospective study. Diabetologia 1992, 35:660-663.
52. Lavery LA, Armstrong DG, Wunderlich RP, et al. Predictive value of foot pressure assessment when part of a population-based diabetes disease management program. Diabetes Care 2003, 26:1069-1073.
53. Cavanagh PR, Ulbrecht JS, Caputo GM What the practicing physician should know about diabetic foot biomechanics. The Foot in Diabetes 2000, 33-60. Wiley, Chichester. 3rd ed. A.J.M. Boulton, H. Connor, P.R. Cavanagh (Eds.).
54. Van Schie CHM, Abbott CA, Vileikyte L, et al. A comparative study of Podotrack, a simple semiquantitative plantar pressure measuring device and the optical pedobarograph in the assessment of pressures under the diabetic foot. Diabet Med 1999, 16:154-159.
55. Murry HJ, Young MJ, Boulton AJM The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996, 13:979-982.
56. Vileikyte L Psychological and behavioural issues in diabetic neuropathic foot ulceration. The Foot in Diabetes 2000, 121-130. Wiley, Chichester. 3rd ed. A.J.M. Boulton, H. Connor, P.R. Cavanagh (Eds.).
57. Valk GD, Kriegsman DM, Assendelf WJ Patient education for reducing diabetic foot ulceration: A systematic review. Endocrinol Metab Clin N Am 2002, 31:633-658.
58. McCabe CJ, Stevenson RC, Dolan AM Evaluation of a diabetic foot screening and prevention programme. Diabet Med 1998, 15:80-84.
59. Young MJ Classification of ulcers and its relevance to ischemia. The Foot in Diabetes 2000, 61. Wiley, Chichester. 3rd ed. A.J.M. Boulton, H. Connor, P.R. Cavanagh (Eds.).
60. Armstrong DG, Lavery LA, Harkless LB Validation of a wound classification system. Diabetes Care 1998, 21:865-869.
61. Oyibo S, Jude EB, Tarawneh I, et al. A comparison of two diabetic foot ulcer classification systems: The Wagner and the University of Texas wound classification system. Diabetes Care 2001, 24:84-88.
62. Schaper NC Diabetic foot ulcer classification system for research purposes: A progress report. Diabet Metab Res Rev 2004, 20(suppl 1):S90-S95.
63. Armstrong DG, Lipsky BA Advances in the treatment of diabetic foot infections. Diabetes Technol Ther 2004, 6:167-177.
64. Edelman D, Hough DM, Glazebrook KN, et al. Prognostic value of the clinical examination of the diabetic foot ulcer. J Gen Intern Med 1997, 12:537-543.
65. Lavery LA, Armstrong DG, Quebedeaux TL, et al. Puncture wounds: The frequency of normal laboratory values in the face of severe foot infections of the foot in diabetic and non-diabetic adults. Am J Med 1996, 101:525-531.
66. Grayson ML, Balaugh K, Levin E, et al. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995, 273:721-723.
67. Lipsky BA Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997, 25:1318-1326.
68. Hirsch AT, Gloviczki P, Drooz A, et al. Special communication: Mandate for creation of a national peripheral arterial disease public awareness program: An opportunity to improve cardiovascular health. Angiology 2004, 55:233-242.
69. Resnick HE, Lindsay RE, McDermott MM, et al. Relationship of high and low ankle brachial index to all cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 2004, 109:733-739.
70. Thomas DW, Harding KG Wound healing. Br J Surg 2002, 89:1203-1205.
71. Jeffcoate WJ, Price P, Harding KG Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab Res Rev 2004, 20(suppl 1):S78-S89.
72. Kirsner RS, Bogensberger G The wound healing process. Wound Healing: Alternatives in Management 1998, 58. FA Davis, Philadelphia. 3rd ed. J.M. McColluch, L.C. Kloth, J.A. Feeder (Eds.).
73. Jeffcoate WJ, Harding KG Diabetic foot ulcers. Lancet 2003, 361:1545-1551.
74. Jude EB, Blakytny R, Bulmer J, et al. Transforming growth factor-b 1, 2, 3 and receptor type 1 and 2 in diabetic foot ulcers. Diabet Med 2002, 19:440-447.
75. Lobmann R, Ambrosch A, Schultz G, et al. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002, 45:1011-1016.
76. Nwomeh BC, Liang HX, Cohen IK, et al. MMP-8 is the predominant collagenase in healing wounds and non-healing ulcers. J Surg Res 1999, 81:189-195.
77. Blakytny R, Jude EB, Gibson JM, et al. Lack of insulin-like growth factor 1 (IGF-1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol 2000, 190:589-594.
78. Jude EB, Boulton AJM, Ferguson MWJ, et al. The role of nitric oxide synthase isoforms and arginase in the patho-genesis of diabetic foot ulcers. Diabetologia 1999, 42:748-757.
79. Boulton AJM, Armstrong DG Studies in plantar diabetic neuropathic ulcers: Time for a paradigm shift?. Diabetes Care 2003, 26:2689-2690.
80. Boulton AJ The diabetic foot: From art to science. The 18th Camillo Golgi lecture. Diabetologia 2004, 47:1343-1353.
81. Piaggesi A, Viacava P, Rizzo L, et al. Semi-quantitative analysis of the histopathological features of the neuropathic foot ulcer-effects of pressure relief. Diabetes Care 2003, 26:3123-3128.
82. Badiavas EV, Falanga V Gene therapy. J Dermatol 2001, 138:1079-1081.
83. Badiavas EV, Falanga V Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003, 139:510-516.
84. Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte function in diabetic patients. Diabet Med 1997, 14:29-34.
85. Zacur H, Kirsner RS Debridement: Rationale and therapeutic options. Wounds 2002, 14(suppl):2E-7E.
86. Steed DL, Donohoe D, Webster MW, et al. Effect of extensive debridement on the healing of diabetic foot ulcers. J Am Coll Surg 1996, 183:61-64.
87. Mueller MJ, Diamond JE, Sinacore DR, et al. Total contact casting in the treatment of diabetic plantar ulcers: Controlled clinical trial. Diabetes Care 1989, 12:384-388.
88. Armstrong DG, Nguyen HC, Lavery LA, et al. Offloading the diabetic foot wound: A randomized clinical trial. Diabetes Care 2001, 24:1019-1022.
89. Lavery LA, Vela SA, Lavery DC, Quebedeaux TL Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations: A comparison of treatments. Diabetes Care 1996, 19:818-821.
90. Baumhauer JF, Wervery R, McWilliams J, et al. A comparison study of plantar foot pressure in a standardized shoe, total contact cast prefabricated pneumatic walking brace. Foot Ankle Int 1997, 18:26-33.
91. Armstrong DG, Lavery LA, Kimbriel HR, et al. Activity patterns of patients with diabetic foot ulceration: Patients with active ulceration may not adhere to a standard pressure offloading regimen. Diabetes Care 2003, 26:2595-2597.
92. Veves A, Sheehan P, Pham HT A randomized controlled trial of Promogran vs standard treatment in the management of diabetic foot ulcers. Arch Surg 2002, 137:822-827.
93. Armstrong DG, Short B, Espensen EH, et al. Technique for fabrication of an 'instant total contact cast' for treatment of neuropathic diabetic foot ulcers. J Am Pod Med Assoc 2002, 92:405-408.
94. Katz I, Harlan A, Miranda-Palma B, et al. A randomised trial of two irremovable offloading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005, 28:555-559.
95. Knowles EA, Armstrong DG, Hayat SA, et al. Offloading diabetic foot wounds using the Scotchcast boot: A retrospective study. Ostomy Wound Manage 2003, 48:50-53.
96. Williams DT, Harding KG New treatments for neuropathic foot ulceration: Views from a wound healing unit. Curr Diab Rep 2003, 3:468-479.
97. Mason J, O'Keefe CO, Hutchinson A, et al. A systematic review of foot ulcers in patients with type 2 diabetes: II. Treatment. Diabet Med 1999, 16:889-909.
98. Lipsky BA, Berendt AR Principles and practice of antibiotic therapy of diabetic foot infections. Diabet Metab Res Rev 2000, 16(suppl 1):542-546.
99. Lipsky BA International consensus on diagnosing and treating the infected diabetic foot. Diabet Metab Res Rev 2004, 20(suppl 1):568-577.
100. Dang CN, Prasad YDM, Boulton AJM, et al. Methicillin-resistant staphylococcus aureus in the diabetic foot clinic: A worsening problem. Diabet Med 2003, 20:159-161.
101. Hartemann-Heurtier A, Robert J, Jacqueminet S, et al. Diabetic foot ulcer and multidrug-resistant organisms: Risk factors and impact. Diabet Med 2004, 21:710-715.
102. Lipsky BA, Itani K, Norden C Treating foot infections in diabetic patients: A randomized, multicentre, open-labelled trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis 2004, 38:17-24.
103. Armstrong DG, Findlow AH, Oyibo S, et al. The use of absorbable antibiotic-impregnated calcium sulphate pellets in the management of diabetic foot infections. Diabet Med 2001, 18:942-943.
104. Weiman TJ, Smiell JM, Su Y Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (Becaplermin) with chronic neuropathic diabetic ulcers: A phase III randomized placebo-controlled study. Diabetes Care 1998, 21:822-827.
105. Bennett SP, Griffiths GD, Schor AM, et al. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 2003, 90:133-146.
106. Veves A, Falanga V, Armstrong DG, et al. Graft skin, a human skin equivalent, is effective in the management of non-infected neuropathic diabetic foot ulcers: A randomized multicenter clinical trial. Diabetes Care 2001, 24:290-295.
107. Marston WA, Hanft J, Norwood P, et al. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomised trial. Diabetes Care 2003, 28:1701-1785.
108. Thomas S Larval therapy. The Foot in Diabetes 2000, 185. Wiley, Chich-ester. 3rd ed. A.J.M. Boulton, H. Connor, P.R. Cavanagh (Eds.).
109. Gill AL, Bell CAN Hyperbaric oxygen: Its uses, mechanisms of actions and outcomes. QJM 2004, 97:385-396.
110. Armstrong DG Guidelines regarding negative wound therapy (NPWT) in the diabetic foot. Ostomy Wound Manage 2004, 50(2 suppl):3S-27S.
111. McCallon SK, Knight CA, Valiulus JP, et al. Vaccum-assisted closure vs saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage 2000, 46:28-34.
112. Mantey I, Foster AN, Spencer S, et al. Why do foot ulcers recur in diabetic patients?. Diabet Med 1999, 16:245-249.
113. Mason J, O'Keefe C, McIntosh A, et al. A systematic review of foot ulcers in patients with type 2 diabetics: I. Prevention. Diabetes Med 1999, 16:801-812.
114. Boulton AJM Why bother educating the patient and the multi-disciplinary team? The example of prevention of lower-extremity amputation in diabetes. Patient Educ Couns 1995, 26:183-188.
115. Cavanagh PR Can footwear help to protect the insensate diabetic foot?. Int Diabetes Monitor 2004, 16:10-16.
116. Knowles EA, Boulton AJM Do people with diabetes wear their prescribed footwear?. Diabet Med 1996, 13:1064-1068.
117. Boulton AJM, Jude EB Therapeutic footwear in diabetes: The good, the bad and the ugly. Diabetes Care 2004, 27:1832-1833.
118. Maciejewski ML, Reiber GE, Smith DG, et al. Effectiveness of diabetic therapeutic footwear in preventing reulceration. Diabetes Care 2004, 27:1774-1782.
119. Colagiuri S, Marsden LL, Naidu V, et al. The use of orthotic devices to arrest plantar callus in people with diabetes. Diabet Res Clin Pract 1995, 28:29-36.
120. Murray HJ, Veves A, Young MJ, et al. Role of experimental socks in the care of the high-risk diabetic foot. A multicentre evaluation study. Diabetes Care 1993, 16:1190-1192.
121. Van Schie CHM, Whalley A, Vileikyte L, et al. Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: A randomized double-blind placebo-controlled trial. Diabetes Care 2000, 23:634-638.
122. Van Schie CHM, Whalley A, Vileikyte L, Boulton AJM Efficacy of injected liquid silicone is related to peak plantar foot pressures in the neuropathic diabetic foot. Wounds 2002, 14:26-30.
123. Van Schie CHM, Whalley A, Armstrong DG, et al. The effect of silicone injections in the diabetic foot on peak plantar pressure and plantar tissue thickness: A 2 year follow-up. Arch Phys Med Rehabil 2002, 83:919-923.
124. Shaw JE, Boulton AJM The Charcot foot. Foot 1995, 5:65-70.
125. Young MJ, Marshall A, Adams JE, et al. Osteopenia, neurological dysfunction and the development of Charcot neuroarthropathy. Diabetes Care 1995, 18:34-38.
126. Selby PL, Young MJ, Boulton AJM Bisphosphonates: A new treatment for diabetic Charcot neuroarthropathy?. Diabet Med 1994, 11:28-31.
127. Gough A, Abraha H, Purewal TS, et al. Measurement of markers of osteoclastic and osteoblastic activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med 1997, 14:517-531.
128. Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the management of Charcot neuroarthropathy: A double-blind randomized controlled trial. Diabetologia 2001, 44:2032-2037.